S100A4 and metastatic malignant neoplasm: S100A4 is expressed in most human metastatic cancers and is associated with the premature death of patients with different types of carcinomas, including those from the breast [10], oral mucosa, bladder, pancreas, prostate, colorectum, oesophagus, lung, stomach [11], and thyroid glands [12,13,14].